Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1613-7671
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis ; volume:132 ; number:1-2 ; day:7 ; month:1 ; year:2020 ; pages:19-26 ; date:1.2020
Wiener klinische Wochenschrift ; 132, Heft 1-2 (7.1.2020), 19-26, 1.2020
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Wakolbinger, Robert
Muschitz, Christian
Wallwitz, Jacqueline
Bodlaj, Gerd
Feichtinger, Xaver
Schanda, Jakob E.
Resch, Heinrich
Baierl, Andreas
Pietschmann, Peter
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00508-019-01595-8
- URN
-
urn:nbn:de:101:1-2020070220410631197451
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wakolbinger, Robert
- Muschitz, Christian
- Wallwitz, Jacqueline
- Bodlaj, Gerd
- Feichtinger, Xaver
- Schanda, Jakob E.
- Resch, Heinrich
- Baierl, Andreas
- Pietschmann, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis
Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences
Bone microarchitecture and bone turnover in hepatic cirrhosis
A patient with liver cirrhosis and hepatic lesions
In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT
Sclerostin and Cardiovascular Disease
Hepatic Encephalopathy Is Not Always due to Liver Cirrhosis
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis
Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
Born Again: Recurrent Hepatic Encephalopathy in an Adult without Cirrhosis
Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis
Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences
Bone microarchitecture and bone turnover in hepatic cirrhosis
A patient with liver cirrhosis and hepatic lesions
In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT
Sclerostin and Cardiovascular Disease
Hepatic Encephalopathy Is Not Always due to Liver Cirrhosis
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis
Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
Born Again: Recurrent Hepatic Encephalopathy in an Adult without Cirrhosis
Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis
Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-Hepatic Influences
Bone microarchitecture and bone turnover in hepatic cirrhosis
A patient with liver cirrhosis and hepatic lesions
In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT
Sclerostin and Cardiovascular Disease
Hepatic Encephalopathy Is Not Always due to Liver Cirrhosis
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis
Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis